Coronavirus (COVID-19)

This page contains medical information for clinicians on the 2019 Novel Coronavirus (COVID-19, also called 2019-nCoV, and now clinically SARS‐CoV‐2). This section includes articles that pertain to clinicians and cardiologists on the virus, new technologies being deployed to fight the virus and clinical information from various sources. Here are direct links for medical professionals to COVID-19 resources from the U.S. Food and Drug Administration (FDA), Centers for Disease Control (CDC) and the World Health Organization (WHO). Daily world-wide statistics on the coronavirus outbreak are available from the WHO Situations Reports. Here is the Centers for Medicare and Medicaid Services (CMS) frequently asked questions and answers (FAQs) for healthcare providers regarding Medicare payment for laboratory tests and other services related to the COVID-19.

The most popular videos in 2021 included the use of ECMO for COVID-19 patients, a demonstration of the Medis QFR angiography image derived FFR system, and the use of remote EP monitoring systems.

Feature

December 26, 2021 — Here is a list of the most popular videos on the DAIC website from the past year in 2021 based on ...

December 26, 2021

Vascular network (red) in healthy heart tissue (left) and in severe Covid-19 (right). Due to faulty reforming of the network as a result of Covid-19, numerous branches, splits and even loops develop in the capillaries, which can be analysed mathematically. Image courtesy of M. Reichardt, P. Møller Jensen, T. Salditt

News | Coronavirus (COVID-19)

Innovative X-ray Imaging Shows COVID-19 Can Cause Vascular Damage to the Heart

December 23, 2021 — An interdisciplinary research team from the University of Göttingen and Hannover Medical School (MHH ...

December 23, 2021

Top stories on COVID-19 related to cardiology in 2021.

Feature | Coronavirus (COVID-19)

Top COVID Content in 2021 Based on What Readers Viewed

COVID-19 was the single biggest topic readers came to DAIC for information in 2021, resulting in more than 300,000 ...

December 16, 2021

Sponsored Content

COVID-19 has posed challenges for physicians whose cardiac patients are at-risk and reluctant to schedule an office visit. Floyd Russak, M.D., of Russak Personalized Medicine, an internal medicine physician practicing in Greenwood Village, Colo., manages many cardiac patients who do not have ready access to a cardiologist

Feature | Wearables

Cardiac Monitoring in the Time of COVID-19: Next Generation Wearable ECG Technology Comes into Its Own

COVID-19 has posed challenges for physicians whose cardiac patients are at-risk and reluctant to schedule an office ...

December 15, 2020

Staff member sets up an ECMO unit for a severely ill COVID-19 patient at Banner Health in Phoenix. A new study shows there is minimal safety risk in transporting patients who need ECMO to a hospital that can provide it as long as PPE requirements and other safety guidelines are met. #COVID19 #SARSCoV2 #ECMO

News | Coronavirus (COVID-19)

No Extra COVID-19 Risk for ECMO Transport Teams

December 7, 2021 – Critically ill patients with COVID-19 can safely be transported for lifesaving extracorporeal ...

December 07, 2021

Videos | Coronavirus (COVID-19)

VIDEO: Cardiac MRI Assessment of Myocarditis Caused by COVID-19 Vaccinations

Kate Hanneman, M.D., MPH FRCPC, director of cardiac imaging research JDMI, and the medical imaging site director at ...

December 06, 2021

News | Coronavirus (COVID-19)

COVID-19 Linked to Heart Inflammation in College Athletes

December 1, 2021 — A small but significant percentage of college athletes with COVID-19 develop myocarditis, a ...

December 01, 2021

Examples of COVID-19 caused clotting with multiple pulmonary embolisms (PE) in left image, and a large thrombus in the aortic arch. Images courtesy of RSNA and Margarita Revzin et al. Find more clinical images of COVID.

News | Coronavirus (COVID-19)

Antiplatelet Drug Class Does Not Increase Survival in Hospitalized Moderate COVID-19 Cases

November 23, 2021 — The antiplatelet drug class of P2Y12 inhibitors that block the activity of platelets and prevents ...

November 23, 2021

Rafael Díaz,M.D., director of Estudios Clínicos Latinoamérica in Rosario, Argentina

News | Coronavirus (COVID-19)

Prescription Omega-3 Pill Did Not Affect Outcome for Non-hospitalized Adults With COVID-19

November 19, 2021 — A high dose of a purified omega-3 fatty acid, available by prescription only, was well tolerated ...

November 19, 2021

People in the U.S. who live in socially vulnerable neighborhoods, which includes communities with higher rates of poverty, crowded living situations and/or a higher proportion of people from diverse racial and ethnic groups, had higher rates of death and cardiac events such as a heart attack or stroke when hospitalized with COVID-19, according to preliminary research presented at the American Heart Association’s Scientific Sessions 2021. #AHA21 #AHA

News | Coronavirus (COVID-19)

People Hospitalized With COVID-19 From Poor Neighborhoods Had Higher Rate of Heart Events

November 17, 2021 — People in the U.S. who live in socially vulnerable neighborhoods, which includes communities with ...

November 17, 2021

SARS-CoV-2 (COVID-19) virus added to cells. Image from the Institute for Molecular Bioscience, The University of Queensland. Image of the COVID-19 Virus

News | Coronavirus (COVID-19)

Vascular Disease in COVID-19 is Not Caused by Viral Infection of Blood Vessels

November 9, 2021 — The COVID-19 (SARS-CoV-2) virus does not infect blood vessels, despite the high risk of blood clots ...

November 09, 2021

A Johns Hopkins Medicine study of nearly 4,500 patients hospitalized with COVID-19 suggests that statins — medications widely used to control cholesterol — are not helpful in reducing COVID-related mortality or the severity of the illness. Graphic created by M.E. Newman, Johns Hopkins Medicine

News | Coronavirus (COVID-19)

Statins Likely Not Helpful In Reducing COVID Mortality or Severity

November 5, 2021 — In the worldwide effort to battle COVID-19 (SARS-CoV-2), researchers have often turned to medications ...

November 05, 2021

Katherine Fornell, age 5, from suburban Chicago, receives her first dose of the COVID-19 vaccine during the first week it became available in the U.S. The FDA authorized the emergency use of the Pfizer-BioNTech COVID-19 vaccine Oct. 29 for the prevention of COVID-19 in children 5 to 11 years of age. This was based on a safety review of more than 3,000 patients receiving the vaccine ages 5-11.

Feature | Coronavirus (COVID-19)

FDA Authorizes Pfizer-BioNTech COVID-19 Vaccine for Children Ages 5-11

November 5, 2021 — The U.S. Food and Drug Administration (FDA) authorized the emergency use of the Pfizer-BioNTech COVID ...

November 05, 2021